Literature DB >> 10233300

Recalcitrant pyoderma gangrenosum treated with systemic tacrolimus.

C C Lyon, B Kirby, C E Griffiths.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10233300     DOI： 10.1046/j.1365-2133.1999.02745.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  3 in total

Review 1.  Diagnosis and treatment of pyoderma gangrenosum.

Authors:  Trevor Brooklyn; Giles Dunnill; Chris Probert
Journal:  BMJ       Date:  2006-07-22

2.  Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial.

Authors:  T N Brooklyn; M G S Dunnill; A Shetty; J J Bowden; J D L Williams; C E M Griffiths; A Forbes; R Greenwood; C S Probert
Journal:  Gut       Date:  2005-09-27       Impact factor: 23.059

3.  Oral tacrolimus for ocular involvement in pediatric neutrophilic dermatoses.

Authors:  Caitlan Swaffar; Diana McShane; Paul Googe; Leonard Kovalick; Dean S Morrell; Eveline Y Wu
Journal:  JAAD Case Rep       Date:  2022-01-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.